Cite
HARVARD Citation
Weinblatt, M. et al. (n.d.). FRI0169 Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with results observed by 2 weeks: Results of the phase 3, multicenter, double-blind, placebo-controlled trial. Annals of the rheumatic diseases. pp. 368-369. [Online].